Bandhan BSE Healthcare Index Fund Regular Plan - Growth
Category: Index Fund
Launch Date: 06-09-2024
AUM:
23.66 Cr
Expense Ratio
1.11%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1IR4
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Abhishek Jain, Mayuresh Nagvekar
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund Regular Plan - Growth | 13.93 | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
₹
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
11.5947
Last change
-0.01 (-0.1104%)
Fund Size (AUM)
₹ 23.66 Cr
Performance
8.14% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in the underlying securities in the same proportion, subject to tracking error. The BSE Healthcare Index will track the performance of companiesthat are part of BSE AllCap belonging to the Healthcare sector.
Fund Manager
Abhishek Jain, Mayuresh Nagvekar
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 12.9 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.69 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.37 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.36 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 5.31 |
| Dr. Reddys Laboratories Ltd | 5.3 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.76 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.73 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.2 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.01 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.02 |